Breast cancer-related lymphedema (BCRL) is a negative sequela of breast cancer
treatment, and well-established risk factors include axillary lymph node dissection (ALND) …

Purpose Breast cancer-related lymphedema (BCRL) represents a lifelong risk for breast
cancer survivors and once acquired becomes a lifelong burden. This review summarizes …

Purpose To evaluate the incidence and risk factors of lymphedema 10 years after surgical
treatment for breast cancer. Methods Prospective observational hospital-based cohort of …

Lymphoedema is an oedematous condition with a specific and complex tissue biology. In
the clinical context of cancer, the pathogenesis of lymphoedema ensues most typically from …

Patients fear lymphedema as an unpredictable daily reminder of breast cancer treatment.
The medical community has assumed for years that the development of breast cancer …

Purpose To review and update the incidence and risk factors for breast cancer-related
lymphedema based on cohort studies. Methods The study was guided by the Joanna Briggs …

The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment
recommendations for common physical and psychosocial consequences of cancer and …

PURPOSE The call to integrate prospective surveillance for lymphedema into cancer care
pathways is building momentum to enable early intervention and prevent the progression of …

PURPOSE To determine whether prophylactic use of compression sleeves prevents arm
swelling in women who had undergone axillary lymph node dissection for breast cancer …

Lymphedema results from lymphatic insufficiency leading to a progressive inflammatory
process that ultimately manifests as discomfort, recurrent infections, and, at times, secondary …